期刊文献+

增加基础胰岛素比例对2型糖尿病患者的疗效观察

Efficacy Increase the Proportion of Basal Insulin in Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的通过增加基础胰岛素比例,观察其对2型糖尿病患者的糖代谢的影响。方法将我院内分泌科住院的在1周内以"3速1长"胰岛素强化方案控制良好的2型糖尿病患者64例,每日其基础胰岛素比例均<30%,所有病例均无严重并发症及伴发症,且肝肾功能正常,按基础胰岛素比例随机分为高比例组(优泌乐25注射液)32例和低比例组(原方案)32例,数据采用SPSS19.0软件进行统计学分析。结果两组患者之间治疗6周后FPG、HbA1c相比较均无统计学意义(P>0.05),但两组间每日胰岛素总量比较有统计学意义(P<0.01)。结论增加基础胰岛素比例,可以减少2型糖尿病患者的胰岛素总量,同样达到血糖良好控制的目的。 Objective To evaluate the influence of the basal insulin on the glycometabolism of the type 2 diabetic patients by increasing the proportion of the basal insulin.Methods 64 type 2 diabetic patients in the endocrinology department, under control of the reinforcement treatment (3 short-acting insulins plus 1 protamine zinc insulin) , with the proportion of daily basal insulin lower than 30%,with no serious complication and normal hepatorenal function, were randomly divided into high proportion group (Lispro 25 injection) and low proportion group (the original treatment) .The data were analyzed statistically with the help of SPSS19.0 software. Results After six weeks' treatment,FPG and HbAlc of the two groups do not differ statistically (P〉0.05) ,compared with the data from the same one collected before the treatment. But the total amount of insulin of the two groups differ stafisticaUy, compared with the data collected after the two months' treatment (P〈0.01) .Condnsion By increasing the proportion ofthe basal insulin,the patients' total amount of insulin can be reduced and plasma glucose will be under control as well.
出处 《中国医药指南》 2014年第19期16-17,共2页 Guide of China Medicine
关键词 2型糖尿病 血糖 基础胰岛素比例 胰岛素总量 Type 2 diabetes mellitus Plasma glucose Proportion of basal insulin Total amount of insulin
  • 相关文献

参考文献3

二级参考文献20

  • 1祝群.新诊断2型糖尿病患者的短期胰岛素强化治疗意义[J].中国实用内科杂志,2005,25(6):560-560. 被引量:48
  • 2李一君,母义明.血糖强化达标的新策略:胰岛素泵治疗和动态血糖监测的临床应用[J].中国实用内科杂志,2007,27(7):502-504. 被引量:47
  • 3Haffner SM, Miettinen H, Chskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans [ J ]. Diabetes,1995,44:1386 -1391.
  • 4Bruce DG, Chishohn DG, Leonare H, et al. Physiolgical importance of deficiency in early prandral insulin secretion in non-insulin-dependent diabetes[ J]. Diabetes, 1988,37:736 - 743.
  • 5American Diabetes Association Workgroup on Hyperglycemia. Defining and reporting hyperglycemia in diabetes[ J]. Diabetes Care, 2005,28 : 1245 - 1249.
  • 6Ohkubo Y, Kishikawa, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus - a randomized prospective 6-year study [ J ]. Diabetes Res Clin Pract,1995,28:103 -117.
  • 7Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study [ J ]. Diabetes Care,2003,26:2598 - 2603.
  • 8Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia[ J ]. Pediatr Diabetes,2006,7:25 - 31.
  • 9Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes [ J]. Diabetes Care ,2005,28: 1568 - 1573.
  • 10Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.

共引文献800

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部